{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:41:29Z","timestamp":1792611689474,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.contraception.2015.07.014","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T05:07:30Z","timestamp":1438232850000},"page":"439-444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Drospirenone-only oral contraceptive: results from a multicenter noncomparative trial of efficacy, safety and tolerability"],"prefix":"10.1016","volume":"92","author":[{"given":"David F.","family":"Archer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Joachim","family":"Ahrendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Drouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.contraception.2015.07.014_bb0085","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/2042098614548857","article-title":"Combined hormonal contraceptives: prescribing patterns, compliance, and benefits versus risks","volume":"5","author":"Brynhildsen","year":"2014","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.contraception.2015.07.014_bb0010","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2015.07.014_bb0015","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2006.12.018","article-title":"Range of published estimates of venous thromboembolism incidence in young women","volume":"75","author":"Heinemann","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.07.014_bb0090","series-title":"Medical eligibility criteria for contraceptive use","author":"WHO","year":"2009"},{"key":"10.1016\/j.contraception.2015.07.014_bb0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/13625189809167250","article-title":"A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75\u03bcg\/day or levonorgestrel 30\u03bcg\/day","volume":"3","author":"Collaborative Study Group","year":"1998","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2015.07.014_bb0095","series-title":"Clinical effectiveness Unit","article-title":"Faculty of sexual and reproductive healthcare","author":"RCOG","year":"2008"},{"issue":"1","key":"10.1016\/j.contraception.2015.07.014_bb0035","first-page":"CD007541","article-title":"Progestin-only pills for contraception","volume":"20","author":"Grimes","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2015.07.014_bb0040","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.07.014_bb0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: Pharmacology and pharmacokinetics of a unique progestogen","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.07.014_bb0100","first-page":"1","article-title":"A randomised study comparing the effect on ovarian activity of a progestogen-only pill (POP) containing desogestrel and a new POP containing drospirenone in a 24\/4 regimen","author":"Duijkers","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2015.07.014_bb0060","series-title":"Yaz\u00ae Summary of Product Characteristics","author":"Healthcare","year":"2015"},{"issue":"7","key":"10.1016\/j.contraception.2015.07.014_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008815.pub3","article-title":"Progestin-only contraceptives: effects on weight (review)","author":"Lopez","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2015.07.014_bb0070","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.104.501502","article-title":"Antihypertensive effects of drospirenone with 17 beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension","volume":"112","author":"White","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.contraception.2015.07.014_bb0110","series-title":"Committee for Medicinal Products for Human Use","article-title":"Guideline on clinical investigation of steroid contraceptives in women","author":"EMA","year":"2005"},{"key":"10.1016\/j.contraception.2015.07.014_bb0080","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/AOG.0b013e3181eb6b0f","article-title":"Using daily text-message reminders to improve adherence with oral contraceptives: a randomized controlled trial","volume":"116","author":"Hou","year":"2010","journal-title":"Obstet Gynecol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782415005065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782415005065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T15:23:08Z","timestamp":1537456988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782415005065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0010782415005065"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2015.07.014","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drospirenone-only oral contraceptive: results from a multicenter noncomparative trial of efficacy, safety and tolerability","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2015.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}